Results 131 to 140 of about 5,905 (203)

Modeling the efficiency of filovirus entry into cells in vitro: Effects of SNP mutations in the receptor molecule

, 2020
Kwang Su Kim, Tatsunari Kondoh, Yusuke Asai, Ayato Takada, Shingo Iwami   +4 more
openalex   +2 more sources

Risk group-4 virus emergent threats. [PDF]

Bioinformation
Shapshak P, Balaji S, Somboonewit C, T Sinnott J, Chiappelli F.   +4 more
europepmc   +1 more source

Emerging Challenges in Filovirus Infections

, 2019
Samuel Okware
openalex   +2 more sources

643. CAdVax-Vectored Multivalent Filovirus Vaccine Protects NHP Against Challenge at 1000 Times the Lethal Dose of Ebola and Marburg Viruses [PDF]

, 2010

openalex   +1 more source

Safety, tolerability, immunogenicity, and plasmapheresis-based antibody collection in a phase 1b open label trial of two investigational monovalent chimpanzee adenoviral vectored filovirus vaccines, cAd3-Sudan and cAd3-Marburg, in healthy adults. [PDF]

EBioMedicine
Vert-Wong E, Stevenson ME, Rustomjee R, Finch CL, Jakubik J, King TH.   +5 more
europepmc   +1 more source

Lack of Lloviu Virus Disease Development in Ferret Model. [PDF]

Emerg Infect Dis
Fletcher P, O'Donnell KL, Rhoderick JF, Henderson CW, Okumura A, Bushmaker T, Takada A, Clancy CS, Kemenesi G, Marzi A.   +9 more
europepmc   +1 more source

eLife assessment: A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus

Bavesh D Kana
openalex   +1 more source

Direct Intercellular Transport Mode of Filovirus Nucleocapsids. [PDF]

Int J Mol Sci
Ibrahim CHO, Takamatsu Y.
europepmc   +1 more source

In Vivo Investigation of Filovirus Glycoprotein-Mediated Infection in a BSL2 Setting. [PDF]

Methods Mol Biol
Richards PT, Briseño JAA, Brunton BA, Maury W.   +3 more
europepmc   +1 more source

Interaction between Filovirus Proteins and Host Cell Membrane

, 2005
Ayato Takada, Takeshi Noda, Yoshihiro Kawaoka   +2 more
openalex   +2 more sources